⌘K

Login Start Free

Home/Filings/4/0000875320-25-000146

4//SEC Filing

Tatsis Ourania 4

Accession 0000875320-25-000146

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:10 PM ET

Size

4.7 KB

Accession

0000875320-25-000146

Insider Transaction Report

Form 4

Period: 2025-03-10

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP, Chief Reg. & Quality Off.

Transactions

Sale
Common Stock
2025-03-10$499.99/sh−3,242$1,620,968→ 51,239 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.

Documents

1 file

4
wk-form4_1741810227.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001789815

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 4:10 PM ET
Size: 4.7 KB

View on SEC.gov